Location: Aqua 300 AB

Morning Session: 8:30 a.m. - 12:00 p.m.

What is adenomyosis?
Elizabeth A. (Ebbie) Stewart, MD
Mayo Clinic College of Medicine

9:30 a.m. - 10:00 a.m.

Break

10:00 a.m. - 10:30 a.m.

Do N-cadherin⁺ Endometrial Epithelial Progenitor Cells Have a Role in Endometriosis and Adenomyosis?
Caroline Gargett, PhD
Monash University

10:30 a.m. - 11:00 a.m.

EH16 4TJEffect of Administration of Selective Progesterone Receptor Modulators (SPRMs) on Uterine and Endometrial Morphology
Lucy Whitaker, MBChB MD
University of Edinburgh
The Queen's Medical Research Institute

11:00 a.m. - 12:00 p.m.

Adenomyotic Lesions as Wounds Undergoing Repeated Tissue Injury and Repair: Evidence and Clinical Implications
Sun-Wei Guo, M.Med, PhD
Fudan University

12:00 p.m. - 1:30 p.m.

Lunch

Afternoon Session: 1:30 p.m. - 5:00 p.m.

1:30 p.m. - 2:30 p.m.

Extracellular Vesicles (EVs) as Messengers in Embryo-maternal Cross Talk
Felipe Vilella, PhD
Valencia University

2:30 p.m. - 3:00 p.m.

STAT3: A key Transcriptional Factor Not Only in Embryo Implantation but Also in Endometrial Regeneration
Yasushi Hirota, MD/PhD
The University of Tokyo

3:00 p.m. - 3:30 p.m.

Novel Therapeutic Targets for Endometriosis
Christian Becker, MD
University of Oxford

3:30 p.m. - 4:00 p.m.

Break

4:00 p.m. - 5:00 p.m.

Forkhead Box A2 (FOXA2) and Endometrial Glands Regulate Uterine Functions for Pregnancy Establishment
Thomas Spencer, PhD
University of Missouri